To the Temple community:

Working in cooperation with the city of Philadelphia, Temple University will begin dispensing COVID-19 vaccines in limited quantities to those who meet city eligibility guidelines. Currently, the city is in Phase 1b for establishing who gets priority for the vaccines. 

As part of Philadelphia’s plans to boost distribution, the university is partnering with the city to begin vaccination the week of March 29. Temple will set up a vaccine clinic on Main Campus that will operate two days per week. Eligible Temple faculty, staff and students who live in the city will receive vaccines on one day and eligible city residents will be vaccinated on the other. All vaccination will be done by invitation and appointment only. There will be no walk-up clinics. Vaccines are being provided to Temple by the city in limited quantities, so it will take some time to accommodate all who want a vaccine. 

Please be aware that due to city requirements, at the present time Temple can only offer COVID-19 vaccines to employees and students who are residents of the city. 

In order to receive an invitation, Temple faculty, staff and students must complete the vaccine interest form. Vaccine supplies remain very limited, so please ensure that the information provided on this form is as accurate as possible. Faculty, staff and students who complete the form will be invited to make an appointment once they are deemed eligible according to city criteria and will be prioritized according to their level of risk.

You should not rely solely on Temple for a COVID-19 vaccination. For the time being, Temple will receive a very limited supply of vaccines. We urge all members of the university community to also sign up with their local communities and health providers to obtain vaccination. 

If you have already been vaccinated, please upload your vaccine information in the patient health portal. 

We will continue to provide updates on the availability and timing of vaccine allocations for the Temple University and surrounding communities. 

Sincerely, 

Mark Denys
Senior Director, Health Services